This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercorelli, B.
Right arrow Articles by Loregian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercorelli, B.
Right arrow Articles by Loregian, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2009, p. 312-315, Vol. 53, No. 1
0066-4804/09/$08.00+0     doi:10.1128/AAC.00988-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity{triangledown}

Beatrice Mercorelli,1 Giulia Muratore,1 Elisa Sinigalia,1 Oriana Tabarrini,2 Maria Angela Biasolo,1 Violetta Cecchetti,2 Giorgio Palù,1* and Arianna Loregian1*

Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, 35121 Padua, Italy,1 Department of Chemistry and Technology of Drugs, University of Perugia, 06123 Perugia, Italy2

Received 24 July 2008/ Returned for modification 6 September 2008/ Accepted 5 November 2008

We identified a 6-aminoquinolone compound, WC5, that inhibits human cytomegalovirus (HCMV) replication with a selectivity index of ~500. WC5 also showed activity against drug-resistant HCMV strains. In contrast, it did not significantly affect the replication of human herpesvirus 6 and 8 and was ~10-fold less active against murine cytomegalovirus. Thus, WC5 may represent a lead for the development of new, potent, and selective anti-HCMV compounds.


* Corresponding author. Mailing address: Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, via Gabelli 63, 35121 Padua, Italy. Phone for A. Loregian: 39 049 8272363. Fax: 39 049 8272355. E-mail: arianna.loregian{at}unipd.it. Phone for G. Palù: 39 049 8272350. Fax: 39 049 8272355. E-mail: giorgio.palu{at}unipd.it

{triangledown} Published ahead of print on 17 November 2008.


Antimicrobial Agents and Chemotherapy, January 2009, p. 312-315, Vol. 53, No. 1
0066-4804/09/$08.00+0     doi:10.1128/AAC.00988-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.